Show simple item record

dc.contributor.advisorEthier, C. Ross
dc.contributor.advisorPardue, Machelle T.
dc.contributor.authorHannon, Bailey Grace
dc.date.accessioned2020-09-08T12:47:26Z
dc.date.available2020-09-08T12:47:26Z
dc.date.created2020-08
dc.date.issued2020-07-22
dc.date.submittedAugust 2020
dc.identifier.urihttp://hdl.handle.net/1853/63648
dc.description.abstractGlaucoma is the leading cause of irreversible blindness in the world, affecting approximately 80 million people in the year 2020. This degenerative optic neuropathy is characterized by retinal ganglion cell (RGC) death, optic nerve damage, and progressive vision loss. While the exact etiology remains elusive, elevated intraocular pressure (IOP) is a known risk factor and lowering IOP remains the only effective treatment. Elevated IOP causes deformation and remodeling of the optic nerve head (ONH) tissues, which in turn is thought to promote localized neurodegeneration. Computational and ex vivo studies have shown that scleral stiffness strongly influences deformation of the ONH, and that increasing the stiffness of the sclera surrounding the ONH (the peripapillary sclera) can significantly reduce these excessive strains. We hypothesize that by crosslinking the collagenous peripapillary sclera, we will reduce mechanical deformation in the ONH, which will in turn mitigate glaucomatous vision loss. To investigate this hypothesis, we developed a safe and efficacious scleral stiffening treatment using the collagen crosslinking agent genipin, assayed through ex vivo and in vivo experiments in healthy rat eyes. We then evaluated our treatment’s efficacy to prevent glaucomatous damage in a microbead rat model of ocular hypertension. Our results indicate that scleral stiffening protected against retinal thinning but did not show protective effects on visual or retinal function, nor preservation of RGC axons. Overall, these results demonstrate the feasibility of using genipin for a scleral stiffening treatment. The absence of a strong protective effect of genipin-induced scleral stiffening on RGC function and structure may be due to limitations in the glaucomatous rat model, in that our model does not mirror the slow progression, nor the moderate IOP elevation characteristic of clinical glaucoma.
dc.format.mimetypeapplication/pdf
dc.language.isoen_US
dc.publisherGeorgia Institute of Technology
dc.subjectGlaucoma
dc.subjectScleral stiffening
dc.subjectCollagen crosslinking
dc.subjectOcular biomechanics
dc.titleStiffening the posterior rat sclera to provide neuroprotection in glaucoma
dc.typeText
dc.description.degreePh.D.
dc.contributor.departmentMechanical Engineering
thesis.degree.levelDoctoral
dc.contributor.committeeMemberPrausnitz, Mark R.
dc.contributor.committeeMemberDixon, J. Brandon
dc.contributor.committeeMemberSamuels, Brian C.
dc.type.genreDissertation
dc.date.updated2020-09-08T12:47:26Z


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record